320,000 Shares in Health Catalyst, Inc. (NASDAQ:HCAT) Acquired by Palogic Value Management L.P.

Palogic Value Management L.P. bought a new stake in Health Catalyst, Inc. (NASDAQ:HCAT) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 320,000 shares of the company’s stock, valued at approximately $2,262,000.

Other institutional investors also recently made changes to their positions in the company. Quest Partners LLC acquired a new position in shares of Health Catalyst in the 3rd quarter valued at approximately $34,000. Quadrature Capital Ltd acquired a new position in shares of Health Catalyst in the 3rd quarter valued at approximately $84,000. Stoneridge Investment Partners LLC acquired a new position in shares of Health Catalyst in the 4th quarter valued at approximately $77,000. Intech Investment Management LLC acquired a new position in shares of Health Catalyst in the 3rd quarter valued at approximately $145,000. Finally, Dynamic Advisor Solutions LLC acquired a new position in shares of Health Catalyst in the 4th quarter valued at approximately $180,000. 85.00% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Duncan Gallagher sold 4,500 shares of the stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $6.98, for a total value of $31,410.00. Following the completion of the transaction, the director now owns 74,438 shares of the company’s stock, valued at approximately $519,577.24. This represents a 5.70 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Daniel Lesueur sold 5,209 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.51, for a total value of $39,119.59. Following the completion of the transaction, the chief operating officer now directly owns 91,253 shares of the company’s stock, valued at approximately $685,310.03. The trade was a 5.40 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 65,530 shares of company stock worth $362,167 in the last three months. 2.50% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages have issued reports on HCAT. Stephens cut their target price on Health Catalyst from $7.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 6th. Stifel Nicolaus lowered their price target on Health Catalyst from $10.00 to $5.00 and set a “hold” rating for the company in a report on Thursday, February 27th. Canaccord Genuity Group lowered their price target on Health Catalyst from $11.00 to $10.00 and set a “buy” rating for the company in a report on Tuesday, January 21st. Royal Bank of Canada lowered their price target on Health Catalyst from $7.00 to $6.00 and set a “sector perform” rating for the company in a report on Thursday, February 27th. Finally, KeyCorp upgraded Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 price target for the company in a report on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $9.27.

Health Catalyst Price Performance

Shares of HCAT opened at $4.33 on Friday. The company has a market cap of $304.01 million, a P/E ratio of -3.21 and a beta of 1.41. The stock has a fifty day moving average price of $5.21 and a 200 day moving average price of $6.98. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. Health Catalyst, Inc. has a 12 month low of $3.76 and a 12 month high of $9.24.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.